A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

NCT05859464 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Malignant Solid Tumor

Interventions

DRUG: ZL-1218
DRUG: Pembrolizumab

Sponsor

Zai Lab (Hong Kong), Ltd.

Collaborators

[object Object]
[object Object]